Pediatric Intestinal Transplant Research and Innovation

Our doctors are known nationally as leaders in intestinal transplant research. We serve as chief investigators and participants in multicenter national studies and clinical trials, as well as conducting novel research of our own. This means that your child has access to the very latest and newest treatments available to achieve a successful intestinal transplant.

To lead and stay up on the very latest innovations, we are active in international and national intestinal health organizations and consortiums, including the Intestinal Transplant Association and the International Intestinal Rehabilitation and Transplant Association.

Recently published intestinal transplant research

Our doctors were active in the following groundbreaking research:

• Precision Delivery of Therapeutics to the Intestine: A Case Series of Superselective Steroid Administration in Pediatric Intestinal Transplant Recipients. Transplantation. Levitte, S., Guevara-Tique, A.A., Ganguly, A., Syed, A., Gugig, R., Zhang K.Y., Bonham, C.A., Thakor, A.S. 2024.

Pioneered a method introducing steroids into veins near the transplanted intestine to treat rejection, in partnership with interventional radiology.

• Mesenchymal stem cell-derived extracellular vesicles for the treatment of acute rejection in pediatric and adult bowel transplant. American Journal of Transplantation. Levitte, S., Zhang, K.Y., Guevara-Tique, A.A., Ganguly, A., Dulken, B.W., Nilkant, R., Rigmaiden, M., Kumari, R., Khlifi, K., Thakor, A.S., Bonham, C.A. 2024.

Completed clinical trial on using mesenchymal stem cells to treat intestinal transplantation rejection.

Stanford Medicine Children’s Health partners with Stanford Medicine to advance research in transplantation through the Stanford Institute for Immunity, Transplantation and Infection, including research specific to intestinal health and transplant. These breakthroughs help us continually improve our care for children with intestinal conditions.